Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6171 |
BI-D1870
|
S6 Kinase; Autophagy | Autophagy; MAPK; PI3K/Akt/mTOR signaling |
BI-D1870 是一种可渗透细胞和透过血脑屏障的的 ATP 竞争性核糖体 S6 激酶抑制剂,抑制 RSK1、RSK2、RSK3和 RSK4 的 IC50值分别为 31 nM、24 nM、18 nM 和15 nM。 | |||
T17314 |
(±)-BI-D
|
Others | Others |
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM). | |||
T25150 |
BI-69A11
BI 69A11,(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one |
NF-κB; Akt | Cytoskeletal Signaling; NF-κB; PI3K/Akt/mTOR signaling |
BI-69A11 ((E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one) 是一种双重 AKT 和 NFkB 通路抑制剂。它通过靶向 Akt 增强结肠癌细胞对 mda-7/IL-24 诱导的生长抑制的敏感性。 | |||
T21867 |
BI-6015
2-甲基-1-(2-甲基-5-硝基苯基磺酰基)-1H-苯并[D]咪唑 |
Others | Others |
BI 6015 是肝细胞核因子 4α (HNF4α) 拮抗剂,可抑制已知 HNF4α 靶基因的表达。它利用 HNF4α 拮抗作用,降低胰岛素启动子活性,可用于研究癌症和糖尿病。 | |||
T68559 |
OUN58101
|
||
OUN58101, also known as MDK-8101, also known as BI-D, is a RSV L-protein inhibitor. OUN58101 was first reported in patnet WO 2005042530. This product has no formal name at the moment. For the convenience of communication, a temporal code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming). | |||
T81790 |
Miptenalimab
BI-754111 |
||
Miptenalimab (BI-754111)为一种高亲和力抗人LAG-3抗体,其对hLAG-3的结合常数(KD)为88.6 nM。该抗体能有效阻断LAG-3与其主要配体MHC-II之间的相互作用。 |